Bridgewest Group Appoints Ivan Mijatovic as General Manager Amid European Expansion Efforts

Bridgewest Group Announces Ivan Mijatovic's New Role

Bridgewest Group, a globally recognized private investment firm dedicated to cultivating innovative solutions in life sciences, software, and deep tech, has recently appointed Ivan Mijatovic as its new Operating Partner and General Manager for Europe. This significant move aligns with the company's strategy to strengthen its presence in the European market while leveraging Mijatovic's extensive background in finance and corporate growth.

Over the past three years, Mijatovic has proven his capability in steering market expansion for multiple organizations. His recent tenure as Chairman of the Board for Pontis Technology marked a period of record growth through strategic acquisitions and operational improvements. Additionally, his involvement with LumaCina, a top-tier pharmaceutical firm known for its sterile injectable solutions, further underscores his diverse expertise across various industries.

Mijatovic’s previous roles showcase a robust career filled with accomplishments. As Managing Partner at VCI Partners, he identified and capitalized on several investment avenues, including Tenex Health, Dxterity Diagnostics, and STARK RFID. His earlier experiences include serving as CFO and Board Chairman for Tenex, as well as a Senior Vice President for Barr Pharmaceutical. Notably, during his tenure with Pliva Pharmaceuticals, one of the largest specialty generic pharma companies worldwide, Mijatovic was pivotal in managing finance and investor relations, enhancing global operations deeply.

In the telecommunications domain, Mijatovic's impact was equally significant. He played a vital role in Deutsche Telekom's international expansion across the US, Europe, and Asia. As Chairman of Hrvatski Telekom, he successfully orchestrated a substantial funding initiative, securing an impressive $850 million investment, and was instrumental in key legislative changes that allowed the company to go public on the Zagreb Stock Exchange.

Dr. Massih Tayebi, Founding Partner and Chairman of Bridgewest Group, expressed confidence in Mijatovic's capabilities, stating, "We are extremely fortunate to have Ivan in this expanded role. His international business acumen has been a tremendous asset in identifying novel business opportunities since our initial investments in Europe four years ago."

Responding to his new responsibilities, Mijatovic expressed enthusiasm about the challenges ahead, stating, "I am honored to take on this role and excited about the opportunity to make a profound impact across the region. The global scope of this position and the chance to drive operational excellence and growth in innovative companies is truly inspiring. I am dedicated to fostering a culture of teamwork, integrity, and collaboration."

With over $3 billion in private capital, Bridgewest Group has a reputation for creating and scaling pioneering businesses. Founded in 1999, it collaborates within its global eco-community to address sectors poised for impactful development, including life sciences, software, semiconductors, and deep technology. The firm boasts a diversified portfolio and seeks to empower its companies through customized financial services and a strong foundation in real estate.

As Mijatovic steps into his expanded role, his leadership is anticipated to drive Bridgewest Group’s strategy further, pushing boundaries within the European market and shaping the company’s future endeavors.

For those curious about what's next for Bridgewest Group, the remarkable journey under Mijatovic's guidance promises to deliver both innovation and success in the ever-evolving European landscape.